Extendicare (EXET.F) Stock Overview
Through its subsidiaries, provides care and services for seniors in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
EXET.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Extendicare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$14.79 |
| 52 Week High | CA$14.83 |
| 52 Week Low | CA$6.72 |
| Beta | 1.08 |
| 1 Month Change | 28.17% |
| 3 Month Change | 55.59% |
| 1 Year Change | 97.60% |
| 3 Year Change | 195.50% |
| 5 Year Change | 188.87% |
| Change since IPO | 107.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| EXET.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 1.3% | 6.1% | 2.9% |
| 1Y | 97.6% | -21.0% | 12.5% |
Return vs Industry: EXET.F exceeded the US Healthcare industry which returned -21.4% over the past year.
Return vs Market: EXET.F exceeded the US Market which returned 11.4% over the past year.
Price Volatility
| EXET.F volatility | |
|---|---|
| EXET.F Average Weekly Movement | 6.0% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: EXET.F has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: EXET.F's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | n/a | Michael Guerriere | www.extendicare.com |
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.
Extendicare Inc. Fundamentals Summary
| EXET.F fundamental statistics | |
|---|---|
| Market cap | US$1.24b |
| Earnings (TTM) | US$64.81m |
| Revenue (TTM) | US$1.13b |
Is EXET.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EXET.F income statement (TTM) | |
|---|---|
| Revenue | CA$1.59b |
| Cost of Revenue | CA$1.36b |
| Gross Profit | CA$227.52m |
| Other Expenses | CA$136.52m |
| Earnings | CA$91.01m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.09 |
| Gross Margin | 14.31% |
| Net Profit Margin | 5.72% |
| Debt/Equity Ratio | 195.1% |
How did EXET.F perform over the long term?
See historical performance and comparisonDividends
Does EXET.F pay a reliable dividends?
See EXET.F dividend history and benchmarks| Extendicare dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2025 |
| Dividend Pay Date | Dec 15 2025 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 17 days |
Does EXET.F pay a reliable dividends?
See EXET.F dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/26 14:49 |
| End of Day Share Price | 2025/11/26 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Extendicare Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tom Callaghan | BMO Capital Markets Equity Research |
| Tania Armstrong-Whitworth | Canaccord Genuity |
| Douglas Loe | Cantor Fitzgerald Canada Corporation |